Agoracom Blog Home

Posts Tagged ‘CSE’

« Older Entries
Newer Entries »

St-Georges $SX $SX.ca $SXOOF Provides Update on #Lithium Processing Technology Initiative & Iceland #Gold Exploration

Posted by AGORACOM-JC at 2:44 PM on Friday, April 24th, 2020
  • Secured vendors and accepted proposals from third-party laboratories to further its lithium metallurgical processing technology’s advanced bench testing and its pilot plant
  • Up to recently, the Company had strategically divided the research workload between various laboratories to protect the intellectual property being developed
  • These segmented R&D silos will now come together and be integrated within the pilot plant operations

Montreal – April 24, 2020 – St-Georges Eco-Mining Corp. (CSE:SX) (CNSX:SX.CN) (OTC:SXOOF) (FSE: 85G1) is pleased to announce that it has secured vendors and accepted proposals from third-party laboratories to further its lithium metallurgical processing technology’s advanced bench testing and its pilot plant.

Up to recently, the Company had strategically divided the research workload between various laboratories to protect the intellectual property being developed. These segmented R&D silos will now come together and be integrated within the pilot plant operations.

As previously announced on February 10, 2020, in the “Winter Update” press release, the Company expected to secure an agreement within the second quarter of 2020. The use of ready-made facilities will generate significant cost reductions and represent a faster alternative than the building of a pilot plant from scratch. St-Georges’ management evaluated different proposals from various potential providers that were intended to meet the Company’s requirements.

The main contractor retained tipped the balance in its favor with a wealth of experience and state-of-the-art, ready-made facilities that only required certain adjustments specific to the St-Georges process. The team expects an adjustment period, and plant trial runs during Q2 and Q3 2020, subject to Quebec COVID-19 confinement releases. Full pilot scale testing should be initiated in or around the beginning of this year Q4.

The Company is expecting to receive materials from Iconic Minerals Ltd. (TSX-V: ICM) in accordance with the next phase of the on-going research and development program in place with the Company. Discussions are being held with various mines operators and mineral developers. Producers of spodumene concentrate have shown interest in supplying material for testing.

Quebec Lithium Resources

St-Georges also sourced material from a Quebec-based lithium project. The Company’s contractors will be preparing 10 to 15 tonnes of material that should yield results of approximately three metric tonnes of industry-grade spodumene concentrate suitable for pilot testing with the St-Georges’ process. The material should be available to the metallurgical team in the weeks following the Quebec government’s lifting of the COVID-19 lock-down. Sourcing local Quebec material qualifies the Company to apply for certain governmental grants, and the Company expects to apply for these grants in 2020.

Enrico Di Cesare, President of St-Georges Metallurgy Corp., commented: “Our partners’ facilities seem built for St-Georges. Under the circumstances, it would be non-sensical to spend time and money to replicate the facilities that they own. These groups have significant experience with concentrating, acids and solutions we will be using. In addition, it de-risks St-Georges by allowing us to focus on development work that is on-going. St-Georges looks forward to working with all our partners at CTMP (Centre de Technologie Minerale et de Plasturgie inc.), which has performed the early development work and will continue to work with the St-Georges team. We feel we will be able to accelerate the development and eventual market acceptance of the products we intend to produce. We believe this combination of laboratory work at bench scale and eventual large-scale pilot plant operations will accelerate our development work. We feel blessed to have two quality partners to move forward with, and we continue our collaborations with universities that specialize in this field of work.“

St-Georges Metallurgy Corp.

On February 27, 2020, St-Georges incorporated a new subsidiary, St-Georges Metallurgy Corp., and appointed Enrico Di Cesare as its President and CEO. This entity is owned 100% by St-Georges and will handle all metallurgical R&D, laboratory partnerships, metallurgical joint ventures, and related intellectual property.

In April, the Company has secured the services of a veteran metallurgist, Mr. Ian J. Cox, to work on the projects with a focus on both lithium and nickel

Ian has a degree in fuel and combustion science, from Leeds University, UK. With post-grad courses in project management from the University of Tennessee, leadership from Harvard, and finance from the Massachusetts Institute of Technology (MIT), he is an experienced project manager/process engineer with extensive experience in new process development and transition from development to design and operation. Ian has built a profitable business in highly competitive international markets. He builds strong multi-function teams with international joint venture/partnering experience.

Iceland Exploration Update

The previously announced work programs in Iceland (See September 3 2019 Press Release), were not finished due to extreme weather conditions. With the arrival of spring and the Icelandic government allowing people to circulate for work as the COVID-19 confinement directives are being eased, the Company expects to be able to finish its Thor sampling program and send those samples to Canada for processing in May, with Vopna and Troll to follow in June-July. No resolution has yet materialized in regard to drilling the Thor property. Management expects to be able to drill this summer, but no certainty can be given in that regard.

Covid-19 Impacts Assessment

The Covid-19 pandemic impacts all of the Company’s Quebec operations. Quebec North-Shore exploration operations are halted until further notice from the government. The Company is using this period to prepare its intervention plan to meet with the First Nations on whose ancestral territory the projects lie. The current process requires 60 to 90 days to receive the relevant permits. It is currently impossible to know when this process will be initiated.

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur Thor Vilhjalmsson”

Vilhjalmur Thor Vilhjalmsson

President and CEO

About St-Georges

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry.

The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Tags: , , , , ,
Posted in St Georges Eco-Mining Technologies | Comments Off on St-Georges $SX $SX.ca $SXOOF Provides Update on #Lithium Processing Technology Initiative & Iceland #Gold Exploration

Ontario to resume issuing new #cannabis store authorizations – SPONSOR: Spyder #Cannabis $SPDR.ca – $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 1:03 PM on Friday, April 24th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

Ontario to resume issuing new cannabis store authorizations

  • Ontario’s cannabis store regulator will resume issuing new store authorizations for stores that have met regulatory requirements, according to a notice posted to its website today.

The Alcohol and Gaming Commission of Ontario (AGCO) hit pause on new Retail Store Authorizations (RSA) in early April due to emergency measures enacted by the province to fight the COVID-19 pandemic.

New store openings in Ontario are essential to maintaining the growth of Canada’s cannabis industry.

Ontario’s five-dozen cannabis stores put the province far behind Alberta and British Columbia – the provincial leaders in marijuana retail – which have opened 181 and 446 stores, respectively.

Despite that, Ontario’s adult-use cannabis sales rose 3% in February to 38 million Canadian dollars ($27 million), leading Canada.

“Restrictions imposed by the emergency order, including the pause to construction work, have delayed many new retailers in the preparation of their stores. However, the AGCO will resume issuing RSAs to those stores that have met all regulatory requirements,” the Alcohol and Gaming Commission of Ontario said in the statement.

Applying for an Retail Operator License (ROL) is the first step for businesses seeking to open a licensed cannabis store in Ontario. It also determines that store operators meet eligibility criteria.

The next step involves Retail Store Authorization (RSA) applications, which deal with the particulars of a physical cannabis store such as location, layout and security plans.

As of early April, Ontario’s cannabis regulator received nearly 900 Retail Operator License (ROL) applications for marijuana stores since it opened up the process to all comers on Jan. 6.

Ontario previously ordered private cannabis stores to close for two weeks as of April 4 because of the coronavirus. Soon after, the stores were given at least a 14-day window to continue serving customers through curbside pickups and home delivery.

Source: https://mjbizdaily.com/ontario-to-resume-issuing-new-cannabis-store-authorizations/

Tags: , , , , , ,
Posted in Spyder Cannabis Inc. | Comments Off on Ontario to resume issuing new #cannabis store authorizations – SPONSOR: Spyder #Cannabis $SPDR.ca – $CGC $ACB $APH $CRON.ca $OGI.ca

CLIENT FEATURE: Else Nutrition Holdings $BABY.ca An Award Winning, Plant-Based Nutrition Company For Small Cap Investors $MAT $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 6:08 PM on Thursday, April 23rd, 2020

Highlights

  • $CAD 10 million cash and runway for well over a year;
  • Backed By A Billion Dollar Global Nutrition Company;
  • MOU For International Distribution Of Products
  • US Product Launch Planned For Q2-2020;
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions

Why Else Nutrition?

  • Gives Small Cap Investors An Opportunity To Participate In Global Paradigm Shift Towards Plant-Based, Clean Label Foods For Toddlers & Children.
  • Entering Commercialization Stage After 7 Years R&D
  • Launching 1st Commercial Product Into US Market Q2
  • 100% Plant-Based, Organic Toddler Nutrition Product 
  • Market Research Survey Finds Over 60% Positive Purchase Intent For Else Product
  • Fills A Market Gap In Plant-Based Toddler Nutrition (12-36 months)
  • Subsidiary Of Billion Dollar Hong Kong Listed Conglomerate (H&H) Owns Approx 11.15% Of BABY
  • H&H Shares Have Voluntary 12-Month Hold
  • H&H Right To Maintain 11.15% Ownership Through Future Financings
  • Patented World’s First 100% Plant Based, Non-Dairy, Non-Soy Baby Formula

Here’s What The Experts Say

“Finally a high quality, nutritionally-dense, tasty, plant-based alternative that is low in sugar.  Else is filling a much needed gap, and providing an alternative for those looking to avoid dairy or soy, and a viable option for intolerances and other diet considerations.”

Nicole Silber, RD, CSP, CLC

Dairy-free, soy-free, plant-based nutrition for babies and toddlers

Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan.

The Product

Else Plant-Based Toddler Nutrition

Dairy-free | Soy-free | Corn Syrup-free | Gluten-free

Made with real, whole foods, it meets the highest standard for nutrition

  • Endorsed by leading pediatricians and nutritionists 
  • Ingredients, vitamins & minerals to support your child’s growth and development
  • 92% whole plant ingredients (almonds, tapioca, buckwheat) 
  • Organic & non-GMO
  • Made by the cleanest process possible
  • Globally patented 

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Else Nutrition Holdings Inc. | Comments Off on CLIENT FEATURE: Else Nutrition Holdings $BABY.ca An Award Winning, Plant-Based Nutrition Company For Small Cap Investors $MAT $KMB $BMY $ABT $WYE

Mota Ventures $MOTA.ca Announces DTC Eligibility for Common Shares $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 9:32 AM on Thursday, April 23rd, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564664/hub/MOTA_Large.png

VANCOUVER, BC / April 23, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTCPINK:PEMTF) (the “Company“) is pleased to announce that it has received approval from the Depository Trust Company (“DTC“) to make the Company’s common shares eligible to be electronically cleared and settled through DTC (“DTC Eligibility“).

DTC is a subsidiary of the Depository Trust and Clearing Corporation, a United States company that manages the electronic clearing and settlement of publicly traded companies. DTC Eligibility incorporates an electronic method of clearing securities that speeds up the receipt of stock and cash, and thus accelerates the settlement process for certain investors. DTC is a member of the U.S. Federal Reserve System, a limited-purpose trust company under New York State banking law and a registered clearing agency with the U.S. Securities and Exchange Commission.

In addition to trading over-the-counter in the United States under the ticker symbol “PEMTF”, the Company’s common shares continue to trade on the Canadian Securities Exchange under the symbol “MOTA” and on the Frankfurt Stock Exchange under the symbol “1WZ”.

“We are very pleased to have obtained DTC eligibility as it simplifies the process of investors and brokers trading and exchanging our stock in the United States, which will benefit Mota and our shareholders. I also expect that being DTC eligible will improve our overall liquidity and help to broaden our shareholder base in North America,” stated Ryan Hoggan, CEO of the Company.

About Mota Ventures Corp.

Mota is an established eCommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the Company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its Nature’s Exclusive brands. Within Europe, its Satavida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Tags: , , , , , , , , , ,
Posted in All Recent Posts, Mota Ventures Corp. | Comments Off on Mota Ventures $MOTA.ca Announces DTC Eligibility for Common Shares $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Hollister Biosciences $HOLL.ca Enters Into Definitive Agreement to Acquire AlphaMind Brands Inc. $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:20 AM on Thursday, April 23rd, 2020
  • Entered into a share exchange agreement dated April 22nd, 2020 among the Company, AlphaMind Brands Inc. and the shareholders of TargetCo
  • Alphamind Brands is developing a portfolio of certified legal mushroom based natural health products
  • The company’s “ready to ship” product SKU’s include Cordyceps, Lion’s Mane, Shiitake, Oyster and Reishi Mushroom based: liquid tinctures, concentrated mushroom powder(s), teas, and chocolate.

VANCOUVER, April 23, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“) – a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that it has entered into a share exchange agreement dated April 22nd, 2020 among the Company, AlphaMind Brands Inc. (“TargetCo“) and the shareholders of TargetCo (the “Definitive Agreement“), pursuant to which, the Company will acquire all of the issued and outstanding shares of TargetCo (the “Proposed Transaction“).  

Alphamind Brands is a Canada and US based growth stage company, that is developing a portfolio of certified legal mushroom based natural health products. It is also actively conducting R&D initiatives, led by Dr. Nikos C. Apostolopoulos, who is exploring psilocybin based pharmaceutical treatments.  The company’s “ready to ship” product SKU’s include Cordyceps, Lion’s Mane, Shiitake, Oyster and Reishi Mushroom based: liquid tinctures, concentrated mushroom powder(s), teas, and chocolate. 

“We are very pleased to have completed the next step in consummating this very exciting acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences, Inc.  “It is a fundamental value of our company to improve the overall health and performance of our customers through our high-quality products and the health benefits associated with medicinal mushrooms are tremendous.  Not to mention, it is our continual objective to broaden our product scope and Alphamind, with its experienced management team, is a perfect foothold for us in the fast-growing market for medicinal mushrooms and complements our existing cannabis and hemp-based product offering.”

“I think we have found a great partner in Hollister”, shared Robert Birmingham, CEO of Alphamind Brands.  “We have medicinal mushroom based product SKU’s ready to ship and R&D is underway to develop an exciting IP portfolio surrounding psilocybin based pharmaceutical treatments. Being under the Hollister umbrella will allow us to access additional markets and leverage their existing manufacturing and distribution infrastructure and will be a fundamental part of the future growth of our business.”

The Proposed Transaction

Pursuant to the terms of the Definitive Agreement, Hollister will acquire all of the issued and outstanding securities of TargetCo in consideration for the issuance of 6,000,000 common shares of the Company (the “Payment Shares“) pro rata to shareholders of TargetCo at a deemed price of $0.20 per Payment Share upon closing of the Proposed Transaction (the “Closing Date“).

The Proposed Transaction remains subject to certain closing conditions including, without limitation, (a) the receipt by Hollister of any necessary corporate and regulatory approval; and (b) each party’s representations and warranties in the Definitive Agreement being true and correct in all aspects as of the Closing Date, and each party meeting its terms and conditions and completing its covenants and obligations as contained therein. There can be no guarantees that the Proposed Transaction will be completed as contemplated or at all.

Hollister will not be assuming any long-term debt; no new control position will be created and there is no change in management or the Board of Directors of Hollister in connection with the Proposed Transaction.

In addition, the Company also reports that it will issue 500,000 common shares at a deemed price of $0.12 per share to an arm’s length consultant pursuant to a consulting agreement in which services were provided from December 1, 2019 to the date hereof.  In addition, the Company will issue 90,400 shares to an arm’s length consultant pursuant to a consulting agreement in which services have been rendered since February 17, 2020 (See press release dated February 25th, 2020).  All shares issued pursuant to the consulting agreements will be subject to a four month and a day hold period from the date of issuance.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

ON BEHALF OF THE BOARD

“Carl Saling”

CEO and Director

The CSE does not accept responsibility for the adequacy or accuracy of this release.

The CSE has not in any way passed upon the merits of the Proposed Transaction and has neither approved nor disapproved the contents of this press release.

The securities to be issued in connection with the Proposed Transaction have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “1933 Act“), or under any state securities laws, and may not be offered or sold, directly or indirectly, or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the 1933 Act) absent registration or an applicable exemption from the registration requirements. This news release does not constitute an offer to sell or a solicitation to buy such securities in the United States.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Tags: , , , , , , ,
Posted in Featured, Hollister Biosciences | Comments Off on Hollister Biosciences $HOLL.ca Enters Into Definitive Agreement to Acquire AlphaMind Brands Inc. $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Tiredness could be ‘human signature’ used to detect bots on Twitter – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 1:21 PM on Wednesday, April 22nd, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

Tiredness could be ‘human signature’ used to detect bots on Twitter

  • Concerns about the impact of deceptive bot networks spreading disinformation in order to influence democratic events, such as the 2016 US presidential election, had lead to calls from lawmakers, academics and campaigners for social media companies to detect and take down these networks
  • These efforts will include human moderators and machine learning algorithms trained to detect suspicious behaviour

By E&T editorial staff

A study has identified short-term behavioural differences between humans and bots – reflecting what is likely to be increasing tiredness towards the end of a social media session – which could be used to detect and take down networks of bots on social media.

Bots – which are controlled by computers, rather than by humans – serve a wide variety of purposes, including news aggregation and customer service. Despite their benefits, bots have come under scrutiny recently in the context of being used manipulatively as part of large-scale, state-backed projects to spread disinformation on social media platforms.

Concerns about the impact of deceptive bot networks spreading disinformation in order to influence democratic events, such as the 2016 US presidential election, had lead to calls from lawmakers, academics and campaigners for social media companies to detect and take down these networks. These efforts will include human moderators and machine learning algorithms trained to detect suspicious behaviour.

Now, a first-of-its-kind study published in Frontiers in Physics has identified some short-term behavioural trends seen in human-run accounts which are absent in bot accounts. This could provide a “human signature” to detect fake accounts, which are constantly adapting to fool detectors.

“Remarkably, bots continuously improve to mimic more and more of the behaviour humans typically exhibit on social media,” said Professor Emilio Ferrara, a University of Southern California computer science expert and co-author of the study. “Every time we identify a characteristic we think is prerogative of human behaviour, such as sentiment of topics of interest, we soon discover that newly developed open-source bots can now capture those aspects.

Ferrara and his colleagues studied how the behaviour of humans and bots changed over the course of single sessions using a large Twitter dataset associated with recent political discussion. They monitored factors such as propensity to engage in various social interactions and volume and type of tweets they wrote, then compared the results between humans and bots.

They found that humans showed an increase in the amount of social interaction over the course of a session (an increase in the fraction of retweets, replies and mentions in a tweet) and a decrease in the amount of content they produce (a decrease in average tweet length). The researchers suggested that this could reflect humans becoming tired towards the end of the session and being less able or willing to produce original content. This behavioural change was not seen in bots.

The researchers used these results to inform a classification system for bot detection. They found that their model significantly outperformed a baseline model in its bot-detection accuracy, indicating that searching for short-term behavioural patterns like this could be valuable in the implementation and improvement of detection systems.

“Bots are constantly evolving: with fast-paced advances in AI, it’s possible to create ever-increasingly realistic bots that can mimic more and more how we talk and interact in online platforms,” said Ferrara. “We are continuously trying to identify dimensions that are particular to the behaviour of humans on social media that can in turn be used to develop more sophisticated toolkits to detect bots.”

Source: https://eandt.theiet.org/content/articles/2020/04/tiredness-could-be-human-signature-used-to-detect-bots-on-twitter/

Tags: , , , , ,
Posted in All Recent Posts, Datametrex AI Limited | Comments Off on Tiredness could be ‘human signature’ used to detect bots on Twitter – SPONSOR: Datametrex AI Limited $DM.ca

Datametrex $DM.ca Awarded $217,000 by Department of National Defence for Completion of Phase 2 of Innovation Program

Posted by AGORACOM-JC at 8:50 AM on Wednesday, April 22nd, 2020
  • Department of National Defence approved the Company’s completion of the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security (IDEaS) program
  • Datametrex will be receiving approximately $217,000 CAD as payment for completion of phase 2
  • Company will continue to work on phase 3 of the program to further develop Nexalogy SMART, Social Media Automated Reporting Technologies

TORONTO, April 22, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Department of National Defence approved the Company’s completion of the second phase of a multi-phase R&D program through the Department of National Defence’s Innovation for Defence Excellence and Security (IDEaS) program. Datametrex will be receiving approximately $217,000 CAD as payment for completion of phase 2.  The Company will continue to work on phase 3 of the program to further develop Nexalogy SMART, Social Media Automated Reporting Technologies. Due to confidentiality requirements, the Company is not permitted to provide additional details about the nature of the work being performed for the Department of National Defence.

IDEaS supports the development of solutions from their conceptual stage, through prototype testing and capability development. The program includes several elements that promote collaboration between innovators, provides developmental resources and provides opportunities to interact with DND’s science and military members. Through which all innovators are on an even playing field to solve specific defence and security challenges. For more info about the program, see here: https://www.canada.ca/en/department-national-defence/programs/defence-ideas.html

“The completion of phase 2, marks the halfway point of this project and reflects the important work we are doing to help the Government of Canada maintain a technological advantage in the realm of cyber social media security. We are happy to have the go ahead to continue the contract.” says Marshall Gunter, CEO of the Company.

For more information on this project or to learn how Datametrex can assist your organization in social media discovery or cyber security please go to: www.nexalogy.com

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com).

For more information about the IDEaS program please visit: Canada.ca/defence-ideas

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Awarded $217,000 by Department of National Defence for Completion of Phase 2 of Innovation Program

Mota Ventures $MOTA.ca Raises $2.8 Million in Additional Private Placement $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 8:03 AM on Wednesday, April 22nd, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564664/hub/MOTA_Large.png

VANCOUVER, BC / ACCESSWIRE / April 22, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTCPINK:PEMTF) (the “Company“) is pleased to announce that it has completed a further offering (the “Offering“) of 9,944,000 units (each, a “Unit“) by way of non-brokered private placement at a price of $0.28 per Unit for gross proceeds of $2,784,320. Each Unit consists of one common share of the Company, and one common share purchase warrant (each, a “Warrant“) exercisable to acquire an additional share at a price of $0.38 for a period of twenty-four months, expiring on April 21, 2022. When combined with the earlier offering completed by the Company on April 1, 2020, the Company has raised gross proceeds of $4,504,320.

The Company anticipates utilizing the proceeds of the Offering to further develop and market products in North America and Europe using its ecommerce sales channels, to satisfy compensation obligations owing to employees based on services provided to the Company and the satisfaction of performance metrics and for general working capital purposes. In connection with completion of the Offering, the Company has paid $75,120 and issued 262,857 common shares and 268,287 Warrants to certain arms-length parties who assisted in facilitating the Offering. The Company has also issued 142,857 Warrants to an arms-length consultant, as partial consideration for services provided to the Company.

All securities issued in connection with the Offering are subject to a four-month-and-one-day statutory hold period in accordance with applicable securities law.

About Mota Ventures Corp.

Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Joel Shacker
President

For further information, readers are encouraged to contact Joel Shacker, President, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Tags: , , , , , , , ,
Posted in All Recent Posts, Mota Ventures Corp. | Comments Off on Mota Ventures $MOTA.ca Raises $2.8 Million in Additional Private Placement $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Empower Clinics $CBDT.ca Continues to Advance Development of #Psilocybin and Psychedelics Division to Address Significant Mental Health Issues $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:20 AM on Wednesday, April 22nd, 2020

Empower is utilizing clinics, physicians, technology and direct access to 165,000 patients to launch dedicated division and resources for psilocybin research.

  • Created a subsidiary company dedicated to the advancement of psilocybin research and patient care, addressing the significant mental health issues of anxiety, depression, post-traumatic stress disorder and addiction
  • “Mental health conditions such as anxiety, depression, addiction and PTSD appear to be on the rise with the onset of the Coronavirus pandemic.” said Steven McAuley, Chairman & CEO of Empower

VANCOUVER, BC / April 22, 2020 / EMPOWER CLINICS INC. (CSE: CBDT)(OTC: EPWCF)(Frankfurt 8EC) (“Empower” or the “Company”), a vertically integrated and growth-oriented life sciences company is pleased to announce, it is has created a subsidiary company dedicated to the advancement of psilocybin research and patient care, addressing the significant mental health issues of anxiety, depression, post-traumatic stress disorder (PTSD) and addiction.

The Company is leveraging its assets that include the existing clinic network, the developing franchise brand, tele-medicine, access to its 165,000 patients and large physician team, to make advancements in psilocybin research and psychedelics therapy in general.

“Mental health conditions such as anxiety, depression, addiction and PTSD appear to be on the rise with the onset of the Coronavirus pandemic.” said Steven McAuley, Chairman & CEO of Empower. “Clinical trials continue to show that psilocybin therapies may provide tremendous help with these conditions, that we see every day in our clinics. As a Company, we must endeavour to utilize our assets and capabilities to positively impact patients’ lives.”

The mental health crisis could cost the world $16 trillion by 2030 according to Future Market Insights and further, the global behavioral health (non-pharmacological) market is expected to be valued at US$156 billion by 2028.

According to the World Health Organization (WHO), depression is the leading cause of disability worldwide, and it is a major contributor to the overall global burden of disease.

The United States Food and Drug Administration has determined that preliminary clinical evidence indicates psilocybin may demonstrate substantial improvement over other available therapies for treatment-resistant depression; and granted a Breakthrough Therapy designation for a treatment that uses psilocybin as a therapy for such depression.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness brand with a network of corporate and franchised health & wellness clinics in the U.S. The Company is building its first hemp-derived CBD extraction facility and produces its proprietary line of cannabidiol (CBD) based products. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

CEO

[email protected]

604-789-2146

Investors: Dustin Klein

SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: , , , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Continues to Advance Development of #Psilocybin and Psychedelics Division to Address Significant Mental Health Issues $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

VIDEO: Datametrex $DM.ca Discusses Obtaining Rights to Import and Sell #COVID19 Test Kits From South Korea

Posted by AGORACOM-JC at 4:29 PM on Tuesday, April 21st, 2020

When US Government Agencies call you in the middle of the greatest health and economic crisis in 100 years to help them detect social media disinformation about COVID-19, it is safe to assume your Artificial Intelligence capabilities to detect fake news, disinformation campaigns and their impact is amongst the most respected in the world.  

But when the Canadian government calls on you to help with the import and sale of COVID-19 test kits from South Korea, it is also safe to assume your trust and security clearances are at the highest levels possible.    

You would probably also assume such a company to be a tech giant or a Silicon Valley funded startup.  But Datametrex AI (DM: TSXV) is neither.  Rather, it is a great Canadian small cap technology company who happens to have:  

“developed strong relationships with many large multi-national companies in South Korea.  As a result of these relationships, the Canadian Embassy in Seoul contacted Datametrex to ask for help in procuring rapid test kits.”

  If that wasn’t enough, Datametrex has also achieved the following as of late:

  • Q3 Revenues Of $1.6 million,  an increase of 186%
  • 9 Month Revenues Of $2.56M an increase of 37%
  • Repeat Contracts Of $1M and $600,000 With Korean Giant LOTTE   
  • $954,000 Contract With Canadian Department of Defence To Fight Social Media Election Meddling
  • Participation In NATO Research Task Group On Social Media Threat Detection 
  • Becoming an affiliate member of the Carnegie Mellon University Center for IDeaS

When a small cap Artificial Intelligence company is successfully deploying its technology with military and conglomerates, as well as, being called upon by the Canadian federal government to ask for help with the greatest pandemic in 100 years, smart small cap investors are compelled to take a closer look.  

That look can begin with our latest interview of Datametrex CEO, Marshall Gunter, who discusses obtaining the rights to import and sell COVID-19 test kits from South Korea and the impact it will have on the Company.  

Watch this interview on one of your favourite screens or hit play and listen to the audio as you drive. 

Tags: , , , , ,
Posted in AGORACOM Via Satellite, Datametrex AI Limited, Featured | Comments Off on VIDEO: Datametrex $DM.ca Discusses Obtaining Rights to Import and Sell #COVID19 Test Kits From South Korea

« Older Entries
Newer Entries »